Michael Burry Background and Investment Philosophy
Michael Burry is a physician turned hedge fund manager who founded Scion Capital, a value-oriented investment fund that gained prominence for predicting the U.S. subprime mortgage crisis before 2008. He is widely known for deep fundamental analysis, concentrated positions, and contrarian trades that challenge market consensus. His approach focuses on identifying mispriced securities by analyzing balance sheets, cash flows, and intrinsic value, often holding positions for several years while waiting for the market to recognize the discrepancy between price and value.
Burry's track record includes exceptional returns during the 2000s, with Scion Capital delivering outsized gains by shorting mortgage-backed securities and credit default swaps tied to subprime loans. He later closed his hedge fund to outside investors and shifted to managing his own capital through Scion Asset Management, a private investment vehicle registered with the U.S. Securities and Exchange Commission. His public 13F filings and letters to investors provide insight into his evolving portfolio and investment theses.
Michael Burry's Current Portfolio and Major Holdings
Recent 13F filings show Michael Burry maintaining concentrated positions in large-cap technology and healthcare companies, with notable holdings in Tesla, Alphabet, and several biotech firms. He has also disclosed significant stakes in companies involved in artificial intelligence, semiconductor manufacturing, and enterprise software, reflecting a continued focus on disruptive innovation and long-term value creation.
Burry's portfolio adjustments often signal conviction in specific sectors or individual stocks, with recent filings highlighting increased exposure to companies with strong free cash flow and durable competitive advantages. His positions in electric vehicle manufacturers and renewable energy firms align with his stated interest in structural shifts in energy and transportation, as detailed in his public commentary and regulatory filings available through the SEC's EDGAR database.
Technology and Healthcare Positions
Within the technology sector, Burry has held substantial stakes in companies leading in cloud computing, digital advertising, and hardware innovation, often emphasizing firms with high barriers to entry and strong intellectual property portfolios. His healthcare holdings include biotechnology and medical device companies, where he targets opportunities in gene therapy, oncology, and advanced diagnostics based on long-term market potential.
Recent Portfolio Changes and Sector Allocation
Analysis of recent quarterly filings indicates shifts in Burry's sector allocation, with increased weight on companies positioned to benefit from artificial intelligence adoption and automation. He has also adjusted exposure to consumer discretionary and industrials, maintaining a value-oriented lens while identifying companies trading below estimated intrinsic value relative to their growth trajectories.
Michael Burry's Market Influence and Public Commentary
Michael Burry remains an influential voice in financial markets, with his public letters, social media commentary, and interviews frequently cited by analysts and investors tracking value-oriented strategies. His warnings about market bubbles, valuation extremes, and systemic risks in specific sectors often precede broader market scrutiny, reinforcing his reputation as a contrarian investor focused on long-term fundamentals.
His investment decisions and public statements continue to move individual stocks and sector trends, particularly in technology and healthcare, where his concentrated positions attract attention from both institutional and retail investors. Regulatory filings and public disclosures provide transparent data on his portfolio, enabling followers to track his thesis in real time through sources such as the SEC's EDGAR system and financial news outlets like Forbes.